206
The use of fluorescent lecthins to detect oral cancer and
dysplasia
J. Kademani
∗
, J. Baeten, A. Johnson, S. Claiborne, M. Idle,
K. Patel, M. Kuriakose, D. Kademani
North Memorial Medical Center, MN, United States
Oral cancer is the sixth most common cancer in the world with
approximately 275,000 people diagnosed each year. Early stage
diagnosis is critical to improve survival. Our study tested a new
oral screening technique based on lecithin histochemistry. The
use of fluorescent lecthins as an adjunct to clinical examination
was more sensitive and accurate than traditional screening meth-
ods, resulting in increased and earlier detection of oral cancer and
dysplasia.
The inclusion criteria were subjects with the following char-
acteristics: (i) absence of risk-habits (tobacco and alcohol usage,
>40 years old or (ii) presence of a clinically suspicious oral lesion
(potentially benign, premalignant, or malignant). The test utilised
fluorescent molecular probes (Dye 1, a nuclear stain-DAPI; and
Dye 2, a lectin-WGA-FITC) were subsequently applied to the oral
cavity. Biopsies of clinically suspicious areas (including areas of
aberrant molecular probe staining) were obtained for histopatho-
logical diagnosis by a board certified oral pathologist. Sensitivity
and specificity metrics for the data were calculated by correlating
fluorescence results to histopathological diagnoses.
This
in vivo
clinical study was performed on 25 patients with a
variety of oral mucosal conditions. The results confirmed a sensi-
tivity of 100% in cancer, 80% in dysplasia with a 60% specificity.
This system is a noninvasive, low-cost and consistent method in
enhancing the early identification of malignant lesions and holds
the promise for earlier detection of oral cancer.
http://dx.doi.org/10.1016/j.ijom.2017.02.700Healing mechanism and osteogenic capacity of bovine bone
mineral—human amniotic mesenchymal stem cell and
autogenous bone graft in critical size mandibular defect
D.B. Kamadjaja
∗
, Purwati, Ferdiansyah, F.A. Rantam,
C. Pramono
Universitas Airlangga, Surabaya, Indonesia
Background:
Maxillofacial bone engineering showed promising
result; however, its healing mechanisms and effectiveness had not
been fully understood.
Objectives:
The study compared the bone healing mechanism and
osteogenic capacity between bovine bone mineral (BBM) scaffold
loaded with human amniotic membrane stem cell (hAMSC) and
autogenous bone graft (ABG) in the reconstruction of critical size
mandibular defect.
Methods:
Critical size defects were made at mandible of 45
New Zealand White rabbits which were subsequently recon-
structed with BBM-hAMSC, BBM alone, and ABG, respectively.
At the end of first, second, and twelfth weeks, five rabbits from
each group were sacrificed for histology and immunohistochem-
istry staining. Expressions of vascular endothelial growth factor
(VEGF), bone morphogenetic protein-2 (BMP-2), Runt-related
transcription factor 2 (Runx2) and angiogenesis were analysed in
first and second week, while Runx2, osteocalcin, collagen-I fibres,
trabecular area and bone incorporation were analysed in twelfth
week.
Findings:
Expressions of VEGF, BMP-2, Runx2 and angiogene-
sis were higher in ABG compared with BBM-hAMSC group in the
first and second week group. In twelfth week expressions of Runx2
and osteocalcin as well as thickness of collagen-I fibres were sig-
nificantly higher in BBM-hAMSC compared to ABG group, while
there was no statistically difference in trabecular area and bone
incorporation between BBMhAMSC and ABG group.
Conclusion:
Early healing activities were higher in ABG than
in BBM-hAMSC, while osteogenic activities in the late stage of
healing were higher in BBM-hAMSC compared to ABG. In addi-
tion, the osteogenic capacity of BBM-hAMSC was comparable to
ABG in the reconstruction of critical size defect in the mandible.
http://dx.doi.org/10.1016/j.ijom.2017.02.701Secreted ectodomain of sialic acid-binding
immunoglobulin-like lectin-9 and monocyte chemoattractant
protein-1 derived from dental pulp stem cells synergistically
regenerate transected rat peripheral nerves by altering
macrophage polarity
F. Kano
∗
, A. Yamamoto, K. Matsubara, H. Hibi
Nagoya University Graduate School of Medicine, Nagoya, Japan
Background:
We previously reported that the implantation of
a collagen graft soaked with serum-free conditioned medium
(CM) from the stem cells of human exfoliated deciduous teeth
(SHED-CM) into the nerve gap promotes neuronal regeneration,
however therapeutic mechanisms are elusive. In another study, we
identified a set of M2 macrophage inducers, monocyte chemoat-
tractant protein-1 (MCP-1) and the secreted ectodomain of sialic
acid-binding immunoglobulin (Ig)-like lectin-9 (sSiglec-9) in
SHED-CM, and showed that they promote functional recovery
after rat spinal cord injury.
Objective:
We examined the therapeutic effects of MCP-1 and
ED-Siglec-9 in the treatment of the peripheral facial nerve injury.
Methods:
The rat facial nerve was resected 5 mm. Next an atelo-
collagen sponge impregnated, MCP-1 and sSiglec-9 was placed
in the nerve gap. The neurological recovery of the transected FN
was assessed by examination of vibrissae movements (VMs), his-
tological analysis with electron microscope, and gene expression
analysis with real-time polymerase chain reaction. Human Schwan
cells (SCs) were cultured for 24 h with CM from MCP-1/sSiglec-
9-induced M2 macrophage (M2-CM). Effects of M2-CM for
proliferation, migration and differentiation of SCs were evaluated.
Results:
SHED-CM or MCP-1/sSiglec-9-treated rats exhibited
markedly improved VMs that were synchronised with that of the
contralateral uninjured side five weeks after injury. The FN of
both treatment groups displayed each many myelinated axons.
M2macrophages converts proinflammatory circumstances to anti-
inflammatory one, and promote to proliferation, migration and
differentiation of SCs.
Conclusion:
SHED-CM and MCP-1/sSiglec-9 may provide a
novel strategy to treat the FNI.
http://dx.doi.org/10.1016/j.ijom.2017.02.702




